- Joined
- Mar 4, 2010
- Messages
- 36,521
- Reaction score
- 85,749
BioNTech, Pfizer
Another company selected as part of Operation Warp Speed, Pfizer (NY, USA) and their German partner BioNTech (Mainz, Germany) started developing their candidates in March. Like Moderna, they are pushing the swift yet unproven mRNA technique, but have this time developed multiple candidates, each of them representing a different combination of mRNA and a target antigen.
Pfizer and BioNTech have since begun Phase I and Phase II clinical trials in Germany and the US, with further tests to follow. Although the vaccine is still under trial, the company is already preparing plans to manufacture millions of doses starting this year, with Pfizer’s CEO stating that he hopes to have a vaccine available for use by the end of October.[/QUOTE]
<respectfully snipped>
DH told me a couple of weeks ago that, in the midst of the pandemic when most of our stocks have tanked, our Pfizer stock has increased exponentially
We've always believed that pharmaceuticals are good investments and hope that Pfizer is on the cutting edge with COVID-19 therapeutics and/or vaccine.
Another company selected as part of Operation Warp Speed, Pfizer (NY, USA) and their German partner BioNTech (Mainz, Germany) started developing their candidates in March. Like Moderna, they are pushing the swift yet unproven mRNA technique, but have this time developed multiple candidates, each of them representing a different combination of mRNA and a target antigen.
Pfizer and BioNTech have since begun Phase I and Phase II clinical trials in Germany and the US, with further tests to follow. Although the vaccine is still under trial, the company is already preparing plans to manufacture millions of doses starting this year, with Pfizer’s CEO stating that he hopes to have a vaccine available for use by the end of October.[/QUOTE]
<respectfully snipped>
DH told me a couple of weeks ago that, in the midst of the pandemic when most of our stocks have tanked, our Pfizer stock has increased exponentially
